Número de descargas:
3453
Número de visitas:
6571
Citas:
0
Compártelo:
Introduction: Many reports in literature have underlined particular features of Lactobacillus paracasei subsp paracasei F19, however a critical review of main clinical outcomes has not been performed so far. Objectives: This review summarizes the most relevant reports, in terms of clinical benefits, of Lactobacillus paracasei subsp paracasei F19 administration reviewing it’s historical background and outlining new interesting perspectives in clinical practice. Methods: We searched Pubmed/Medline using the terms “ Lactobacillus paracasei subsp paracasei F19”. All clinical and experimental articles on the use of Lactobacillus paracasei subsp paracasei F19 were included. Results and discussion: The genetic stability of F19, the most relevant clinical claim, renders it’s administration reliable and effective in immunocompromised people. Adequate concentrations of this strain support a dose/effect strategy ranging between NF B host macro - phage activation to pathogenic bacteria overgrowth control as well as to fine interaction with the gut nerve endings. Moreover preliminary results from our lab support the formulation of F19 encapsulated with lyophilized HA in patients with IBD due to both an increased mucous-strain adherence and a possible enhanced strain proliferation and maintenance. Conclusions: Further experiments are required to overcome the lack of informations about this new formulation for IBD management.
Palabras Clave: Lactobacillus paracasei subsp paracasei F19. Lactic acid bacteria. Probiotic.
Mª José Sendrós Madroño
María Dolores Ballesteros Pomar , Elena González Arnaiz
Ana Isabel Jiménez-Ortega , Rosa María Martínez García , Marta Velasco Rodríguez-Belvis , Ana Belén Martínez Zazo , María Dolores Salas-González , Esther Cuadrado-Soto
Francisco Guarner
Ariana Rodríguez Arreola , Josué R. Solís Pacheco , Monique Lacroix , Edgar Balcazar López , Rosa Elena Navarro Hernández , Flavio Sandoval-Garcia , José Alfonso Gutiérrez Padilla , Elisa García Morales , Blanca Rosa Aguilar Uscanga
Ana Maria Campos Martinez , Carmen Elizabeth Fernández Marín , Aida Ruiz López , Isabel Cubero Millán , José Uberos Fernández
Kaiwen Sun , Zhenzhu Liu , Hongyan Wang
Sonia López-Cisneros , Ailema González-Ortiz , Samuel Ramos-Acevedo , Ángeles Espinosa-Cuevas
Julián Herrera Mejía , Arnulfo Ramos-Jiménez , Florinda Jiménez Vega , Rocío Campos Vega , Aaron F. González Córdova , Abraham Wall-Medrano
YanPing Liu , Dejian Ma , XiYan Wang , YunZhi Fang
Qiwei Xie , Jiatian Yuan , Yaoweng Wang
Merve Tokpunar , K. Esen Karaca Çelik , Murat Baş , Hakan Kuleaşan , Aylin Korkut Altıntaş
Gözde Okburan , Murat Baş , Sultan Ogmen
Fatma Özgüç Çömlek , Muslu Kazım Körez
Sibel Bulut , Seray Kabaran
Ante cualquier agresión, el organismo pone en marc...
El paciente crítico presenta una respuesta metaból...